Publisher
source

Zeger Debyser

Top university

Just Landed

2 days ago

PhD in LINE-1 Retrotransposition and Inhibitor Development at KU Leuven KU Leuven in Belgium

Degree Level

PhD

Field of study

Cell Biology

Funding

Supervised doctoral project with initial one year of start-up funding. The candidate must subsequently apply for and defend an FWO doctoral fellowship in 2027; the post highlights a strong track record in securing FWO doctoral grants.

Deadline

Dec 24, 2026

Country flag

Country

Belgium

University

KU Leuven

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

Apply for this position

Keywords

Cell Biology
Pharmacology
Biochemistry
Molecular Biology
Virology
Biomedical Engineering
Medicine
Biology
Neuropsychology
Medical Science
Pharmacy
Pharmaceutical Chemistry
bio engineering

Suggested positions

About this position

Doctoral candidate with application for an FWO grant at KU Leuven (Leuven, Belgium) in the interdisciplinary research facility Molecular Medicine within the Department of Pharmaceutical and Pharmacological Sciences.

The project is led by Prof. Dr. Zeger Debyser and focuses on human LINE-1 retrotransposition, host factors that facilitate LINE-1 transposition, and the development of inhibitors in cell culture and animal models. The research also uses IPSC-derived human neuron cultures, linking the work to molecular medicine, virology, neuroinflammatory disease mechanisms, and translational biomedical research.

This is a PhD opening with initial one year of start-up funding. The successful candidate must later apply for an FWO doctoral fellowship in 2027 and meet the FWO selection criteria. The post emphasizes that the group has a strong track record in securing FWO doctoral grants.

Eligibility highlights: Master in Biomedical, Pharmaceutical or Biochemical Sciences, or Master in Medicine or Bioengineering. Prior thesis experience in biochemistry, molecular biology, cell biology, virology, or computer science is advantageous. Experience with laboratory animals (mice) is a bonus.

Application deadline: 24 December 2026, 23:59 CET. Apply via the KU Leuven online application system.

Funding details

Supervised doctoral project with initial one year of start-up funding. The candidate must subsequently apply for and defend an FWO doctoral fellowship in 2027; the post highlights a strong track record in securing FWO doctoral grants.

What's required

Master in Biomedical, Pharmaceutical or Biochemical Sciences, or Master in Medicine or Bioengineering. Motivation to work in a group on a new research line is required. Prior master's thesis experience in biochemistry, molecular biology, cell biology, virology, or computer science is an advantage. Experience with laboratory animals (mice) is a bonus. The candidate must apply for an FWO doctoral fellowship in 2027 and meet FWO selection criteria, including being in the top 20 students.

How to apply

Apply through the KU Leuven online application system before 24/12/2026 23:59 CET. For questions, contact Prof. Dr. Zeger Debyser or Ms. Kune Herrebosch by email.

More information can be found here

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?

Professors